First Read: AeroVironment Inc "Investor day takeaways - bullish outlook..."

Research evidence excerpt

First Read: AeroVironment Inc "Investor day takeaways - bullish outlook..."

Upside to numbers could come from a variety of places, with the largest

opportunity potentially being counter-UAS, where further adoption and use cases

could drive incremental upside, and international and commercial markets.

Commercial/civil counter-UAS opportunity could ultimately exceed the size of

the defense market, according to management.

Current financial profile

FY27 is expected to be an investment year, with elevated spending in IRAD,

SG&A, and capital projects pressuring near-term margins.

Since FY24, approximately $283mn of Capex has been deployed:

74% production, facilities, and capacity expansion

13% IT infrastructure

13% maintenance

Free cash flow will be negative in FY27 but turns positive in FY28 and improves

progressively through FY30.

M&A remains focused on capability enhancement rather than achieving FY30

growth targets.

Operational execution, capacity, and investment

Execution with excellence, including capacity expansion, supply chain resiliency,

domestic / allied sourcing, and balanced IRAD spending across new and existing

platforms.

92% dual-sourced parts, 98% domestically or allied-produced UAV

components.

Manufacturing investment is expected to peak in FY27, including $65mn of

facilities Capex and $130mn of capacity Capex, with investment directed toward

strike, multi-mission ISR, and counter-UAS production scale-up.

Capacity investment by segment includes ~$60mn for up to ~$2bn of strike

capacity, ~$50mn for up to ~$1bn of multi-mission ISR capacity, and ~$20mn for

up to ~$1bn of counter-UAS capacity.

Capex is expected to normalize to ~5-6% of revenue after FY27, while

management expects working-capital improvements and a shorter cash-